196 related articles for article (PubMed ID: 35614510)
1. Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana.
Opoku S; Sakyi SA; Ayisi-Boateng NK; Enimil AK; Senu E; Ansah RO; Aning BD; Ojuang DA; Wekesa DN; Ahmed FO; Okeke CB; Sarfo AD
AIDS Res Ther; 2022 May; 19(1):21. PubMed ID: 35614510
[TBL] [Abstract][Full Text] [Related]
2. Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study.
Chendi BH; Okomo Assoumou MC; Jacobs GB; Yekwa EL; Lyonga E; Mesembe M; Eyoh A; Ikomey GM
BMC Infect Dis; 2019 Feb; 19(1):194. PubMed ID: 30808298
[TBL] [Abstract][Full Text] [Related]
3. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with anti-retroviral therapy (ART) adherence among adult people living with HIV (PLWH): A 5-year retrospective multi-centre study in Kumasi, Ghana.
Senu E; Sakyi SA; Ayisi-Boateng NK; Enimil AK; Opoku S; Ansah RO; Aning BD; Ojuang DA; Wekesa DN; Ahmed FO; Okeke CB; Sarfo AD; Kwofie GS; Amoani B
Dialogues Health; 2022 Dec; 1():100082. PubMed ID: 38515921
[TBL] [Abstract][Full Text] [Related]
5. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
[TBL] [Abstract][Full Text] [Related]
6. Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand.
Kyaw NL; Thanachartwet V; Kiertiburanakul S; Desakorn V; Chamnanchanunt S; Chierakul W; Manosuthi W; Pitisuttithum P; Sungkanuparph S
Southeast Asian J Trop Med Public Health; 2013 Mar; 44(2):232-43. PubMed ID: 23691633
[TBL] [Abstract][Full Text] [Related]
7. Virologic Response Following a Switch to Dolutegravir-based Regimen in People Living with HIV/AIDS at a Tertiary Care Center in Nepal.
Tamrakar R; Tamrakar D
Kathmandu Univ Med J (KUMJ); 2022; 20(80):438-442. PubMed ID: 37795720
[TBL] [Abstract][Full Text] [Related]
8. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication.
Ioannidis JP; Havlir DV; Tebas P; Hirsch MS; Collier AC; Richman DD
AIDS; 2000 Jul; 14(11):1481-8. PubMed ID: 10983634
[TBL] [Abstract][Full Text] [Related]
10. Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.
Havlir DV; Hellmann NS; Petropoulos CJ; Whitcomb JM; Collier AC; Hirsch MS; Tebas P; Sommadossi JP; Richman DD
JAMA; 2000 Jan; 283(2):229-34. PubMed ID: 10634339
[TBL] [Abstract][Full Text] [Related]
11. Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Munderi P; Walker AS; Kityo C; Babiker AG; Ssali F; Reid A; Darbyshire JH; Grosskurth H; Mugyenyi P; Gibb DM; Gilks CF;
HIV Med; 2010 May; 11(5):334-44. PubMed ID: 20136661
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017.
Rich SN; Cook RL; Yaghjyan L; Francois K; Puttkammer N; Robin E; Bae J; Joseph N; Pessoa-Brandão L; Delcher C
PLoS One; 2020; 15(10):e0240817. PubMed ID: 33119631
[TBL] [Abstract][Full Text] [Related]
13. Clinical profile and predictors of viral suppression in HIV-infected older adults at a University Hospital in Kumasi, Ghana.
Ayisi-Boateng NK; Opoku DA; Nkrumah I; Frempong B; Owusu M; Oduro E; Ampah BA; Konadu E; Norman B
AIDS Care; 2023 Dec; 35(12):1821-1829. PubMed ID: 36120907
[TBL] [Abstract][Full Text] [Related]
14. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana.
Obiri-Yeboah D; Pappoe F; Baidoo I; Arthur F; Hayfron-Benjamin A; Essien-Baidoo S; Kwakye-Nuako G; Ayisi Addo S
BMC Infect Dis; 2018 May; 18(1):230. PubMed ID: 29783953
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana.
Nii-Trebi NI; Ibe S; Barnor JS; Ishikawa K; Brandful JA; Ofori SB; Yamaoka S; Ampofo WK; Sugiura W
PLoS One; 2013; 8(8):e71972. PubMed ID: 23977189
[TBL] [Abstract][Full Text] [Related]
16. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
17. Serum Interleukin-6 and Weight Loss in Antiretroviral-naïve and Antiretroviral-treated Patients with HIV/AIDS: Relationships and Predictors.
Adedeji TA; Adedeji NO; Ajeigbe AK; Smith OS; Jeje OA; Fawale MB; Ajose AO; Adebisi SA; Akande AA; Okesina BA
Curr HIV Res; 2022; 20(6):441-456. PubMed ID: 36056868
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
Laurent C; Bourgeois A; Mpoudi-Ngolé E; Ciaffi L; Kouanfack C; Mougnutou R; Nkoué N; Calmy A; Koulla-Shiro S; Delaporte E
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):393-9. PubMed ID: 18327976
[TBL] [Abstract][Full Text] [Related]
20. Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
Goodall RL; Dunn DT; Nkurunziza P; Mugarura L; Pattery T; Munderi P; Kityo C; Gilks C; Kaleebu P; Pillay D; Gupta RK;
J Antimicrob Chemother; 2017 May; 72(5):1450-1455. PubMed ID: 28160504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
